Barrier Cream vs. Cream Balm: Humectant, Emollient, and Occlusive Ingredient Systems

Definition

• Humectant, emollient, and occlusive are the three functional groups conventionally used to classify skin-conditioning ingredients in moisturizer science (Lodén, Am J Clin Dermatol 2003;4(11):771-788): humectants draw and bind water into the stratum corneum (e.g., via hygroscopic -OH/-COOH groups); emollients fill intercellular gaps between corneocytes and impart slip/softness without necessarily blocking water loss; occlusives form a hydrophobic film on the skin surface that measurably slows transepidermal water loss (TEWL) - the U.S. FDA's OTC skin-protectant monograph at 21 CFR 347.10 (govinfo.gov/eCFR) is the clearest primary-regulatory list of ingredients recognized to occlude and protect skin, each with an approved concentration range.
• 'Barrier cream' here denotes a topical O/W (oil-in-water) emulsion in which water is the continuous phase and the largest single ingredient by weight (confirmed on official INCI listings, e.g., CeraVe Moisturizing Cream: Aqua/Water is INCI-first). 'Cream balm' denotes a wax/butter/oil-structured system formulated with little or no added water - U.S. Patent 11,278,479 B2 (L'Oréal SA, 'Moisturizing anhydrous butter balm composition and method', filed 2020-06-08, granted 2022-03-22) defines its balm as 'essentially anhydrous,' capping water at not more than 5 wt%, preferably under 1 wt%, and structured instead by plant butters (20-30% combined), waxes (1.5-20% combined) and triglyceride oils (40-50% combined). A real-world balm/ointment example carrying an FDA drug label, Aquaphor Healing Ointment (DailyMed setid 0a17bf6f-6114-4647-a509-65999255c37b), lists Petrolatum 41% as its sole active ingredient and Mineral Oil, Ceresin, Lanolin Alcohol, Panthenol, Glycerin, and Bisabolol/Levomenol as inactives - with no water ingredient declared at all.

System name

• Barrier cream (oil-in-water emulsion)
• Cream balm / anhydrous-to-near-anhydrous balm

Member ingredients

• HUMECTANTS - draw/bind water into stratum corneum: Glycerin (FDA 21 CFR 347.10 lists it as a skin-protectant active at 20-45%, though cosmetic-science literature per Lodén 2003 classifies it functionally as the archetypal humectant - noting this dual FDA-vs-cosmetic-science classification rather than resolving it); Propanediol (US11278479B2 claims 1-10 wt% as humectant); Sodium Hyaluronate (present in CeraVe Moisturizing Cream official INCI); Panthenol (present in both CeraVe Moisturizing Cream INCI and the Aquaphor Healing Ointment FDA label).
• EMOLLIENTS - fill intercellular gaps, impart slip/softness: Caprylic/Capric Triglyceride, Cetearyl Alcohol, Cetyl Alcohol (all official CeraVe Moisturizing Cream INCI); Triglyceride plant oils such as sunflower and soybean oil, 40-50 wt% combined per US11278479B2; plant butters (shea, cacao, murumuru), 20-30 wt% combined per US11278479B2, which are dual-function emollient/near-occlusive depending on melting point and film continuity - the patent and the FDA monograph do not agree on a single category for butters, so both functional readings are kept side by side rather than forced to one.
• OCCLUSIVES - form a hydrophobic film that slows TEWL, per FDA 21 CFR 347.10 approved concentration ranges: Petrolatum / White Petrolatum (30-100%), Mineral Oil (50-100%, or 30-35% combined with colloidal oatmeal), Lanolin (12.5-50%), Dimethicone (1-30%), Cocoa Butter (50-100%), Hard Fat (50-100%). Ceresin (microcrystalline wax) and Lanolin Alcohol appear as occlusive/structuring waxes on the Aquaphor Healing Ointment FDA label but are not separately scheduled with a percentage range in 21 CFR 347.10 - flagged as label-confirmed but not monograph-quantified.
• STRUCTURAL SPLIT - water phase share: cream systems run water-majority/water-continuous (a studied pediatric barrier cream held 58% purified water in its original composition and up to 100% of an expanded water phase after reformulation, per Kovács et al., Pharmaceutics 2020;12(8):729; commercial O/W creams such as CeraVe Moisturizing Cream list Aqua/Water as the INCI-first, i.e., highest-concentration, ingredient); balm systems are capped at ≤5 wt% water, preferably <1 wt%, per US11278479B2, and the Aquaphor Healing Ointment FDA label declares no water ingredient at all.
• STRUCTURAL SPLIT - occlusive load: the balm/ointment example is occlusive-dominant, single-phase (Petrolatum listed as the sole 41% active ingredient on the Aquaphor FDA label, within the 30-100% range 21 CFR 347.10 allows); the cream example carries occlusives (Petrolatum, Dimethicone) as minor, INCI-mid-list components behind water, glycerin, and emulsifying alcohols (CeraVe Moisturizing Cream official INCI order), i.e., occlusion is supplementary rather than the base structure.
• STRUCTURAL SPLIT - emulsifier type: cream systems require a true O/W emulsifier - Polysorbate 60 (nonionic) at 4% in the Kovács et al. 2020 study formulation, or Cetearyl Alcohol/Ceteareth-20/Behentrimonium Methosulfate (fatty-alcohol/nonionic/cationic co-emulsifier system) per CeraVe Moisturizing Cream official INCI. Balm systems, being essentially anhydrous, need no true emulsifier: the Aquaphor Healing Ointment FDA label contains none, and structure instead comes from wax (Ceresin); US11278479B2 does list Glyceryl Stearate (2-20 wt%) but frames it as part of the fatty/ester phase of an 'essentially anhydrous' system rather than a conventional O/W emulsifier, since there is no substantial water phase to emulsify.
• STRUCTURAL SPLIT - families unique to one system: water-phase-dependent additives found in the cream example but absent from the balm/ointment example include a gelling/viscosity agent (Carbomer, Xanthan Gum), a chelator (Disodium EDTA), pH-buffering phosphate salts (Potassium Phosphate, Dipotassium Phosphate), and a preservative system (Phenoxyethanol, Ethylhexylglycerin) - all per CeraVe Moisturizing Cream official INCI; none of these appear on the Aquaphor Healing Ointment FDA label, consistent with an anhydrous system having no water activity to preserve, buffer, or gel. Conversely, wax structurants (e.g., Ceresin) are load-bearing in the balm/ointment example and only minor-to-absent in the cream example.
• RATIO CAVEAT (explicit, per editor instruction): the widely cited 3:1:1 molar ratio of ceramide:cholesterol:free fatty acid for optimal stratum corneum barrier repair originates from Man MQ, Feingold KR, Thornfeldt CR, Elias PM, 'Optimization of physiological lipid mixtures for barrier repair,' J Invest Dermatol. 1996;106(5):1096-1101 - an experimental lipid-application study, not a product-label analysis. An INCI list (e.g., CeraVe Moisturizing Cream's Ceramide NP, Ceramide AP, Ceramide EOP, Cholesterol, Phytosphingosine sequence) only reflects descending order of concentration for ingredients above roughly 1%, with no disclosed molar or weight ratio; below ~1% concentration, EU/FDA labeling conventions do not require concentration-ordered listing at all. No product INCI list in the sources reviewed can be used to confirm, refute, or estimate a 3:1:1 (or any other) ratio - this is stated plainly rather than inferred.

All research records · Corrections: see our corrections policy.